Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
alessandro.sciarra@uniroma1.it
Alessandro Sciarra
Professore Ordinario
Struttura:
DIPARTIMENTO MATERNO INFANTILE E SCIENZE UROLOGICHE
E-mail:
alessandro.sciarra@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Exosome Analysis in Prostate Cancer: How They Can Improve Biomarkers’ Performance
CURRENT ISSUES IN MOLECULAR BIOLOGY
2023
Is It Time to Anticipate the Use of PARP Inhibition in Prostate Cancer Patients?
CURRENT ONCOLOGY
2023
INTERMITTENT VERSUS CONTINUOUS ANDROGEN DEPRIVATION THERAPY FOR BIOCHEMICAL PROGRESSION AFTER PRIMARY THERAPY IN HORMONE-SENSITIVE NON-METASTATIC PROSTATE CANCER: COMPARATIVE ANALYSIS IN TERMS OF CRPC-M0 PROGRESSION
CLINICAL GENITOURINARY CANCER
2023
Design of a magnetic resonance imaging-based screening program for early diagnosis of prostate cancer: preliminary results of a randomized controlled trial-Prostate Cancer Secondary Screening in Sapienza (PROSA)
EUROPEAN RADIOLOGY
2023
Robot-Assisted Sacrocolpopexy versus Trans-Vaginal Multicompartment Prolapse Repair: Impact on Lower Bowel Tract Function
BIOMEDICINES
2023
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors
WORLD JOURNAL OF UROLOGY
2023
Comparison of Four Validated Nomograms (Memorial Sloan Kettering Cancer Center, Briganti 2012, 2017, and 2019) Predicting Lymph Node Invasion in Patients with High-Risk Prostate Cancer Candidates for Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Clinical Experience and Review of the Literature
CANCERS
2023
Long term follow-up outcomes of pelvic floor rehabilitation in subjects suffering from lifelong premature ejaculation: Retrospective multicentre study
EUROPEAN UROLOGY. SUPPLEMENTS
2023
Investigating the role of the prostate multiparametric magnetic resonance imaging sequences quality on biopsies’ outcomes
EUROPEAN UROLOGY. SUPPLEMENTS
2023
Trends and incidence of reported events associated with ureteroscopes: An analysis of the food and drug administration’s manufacturer and user facility device experience database
EUROPEAN UROLOGY. SUPPLEMENTS
2023
New minimally invasive techniques versus turp for middle volume (30-80 ml) prostates: A prospective randomized study
EUROPEAN UROLOGY. SUPPLEMENTS
2023
Trends and incidence of reported events associated with ureteral stents: An analysis of the food and drug administration’s manufacturer and user facility device experience database
EUROPEAN UROLOGY. SUPPLEMENTS
2023
Metabolic syndrome evaluation improves prostate cancer detection in patients undergoing a repeat biopsy
EUROPEAN UROLOGY. SUPPLEMENTS
2023
Trends and incidence of reported events associated with male slings: An analysis of the food and drug administration’s manufacturer and user facility device experience database
EUROPEAN UROLOGY. SUPPLEMENTS
2023
NEW MINIMALLY INVASIVE TECHNIQUES VERSUS GOLDSTANDARD TREATMENT FOR MIDDLE VOLUME (30-80 ML)PROSTATES: A PROSPECTIVE RANDOMIZED STUDY
THE JOURNAL OF UROLOGY
2023
DOES EARLY INTRODUCTION OF SELF INTERMITTENT CATHETERIZATION IMPROVE FUNCTIONAL OUTCOMES AND URINARY INFECTION IN ORTHOTOPIC ILEAL NEOBLADDER? RESULTS FROM A PROSPECTIVE MULTICENTRE STUDY
THE JOURNAL OF UROLOGY
2023
Translation and validation of the Italian version of the Wisconsin Stone Quality of Life Questionnaire (I-WISQOL) for assessing quality of life in patients with urolithiasis
MINERVA UROLOGY AND NEPHROLOGY
2023
Impact of early self-clean intermittent catheterization in orthotopic ileal neobladder: prospective randomized study to evaluate functional outcomes, continence status and urinary tract infections
MINERVA UROLOGY AND NEPHROLOGY
2023
A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors
ASIAN JOURNAL OF UROLOGY
2023
Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence
JOURNAL OF PERSONALIZED MEDICINE
2023
« prima
< precedente
1
2
3
4
5
6
7
8
9
seguente ›
ultima »
Progetti di Ricerca
Evaluation of serum thymidine kinase 1 (TK1) as a biomarker for follow-up and prediction of progression in early-stage and advanced prostate cancer patients.
Valutazione dei tratti premorbosi temperamentali e degli stili di coping nello sviluppo di Disturbi Depressivi in pazienti affetti da neoplasia prostatica: influenza delle diverse terapie oncologiche e degli aspetti funzionali.
Implementation of SelectMDx non-invasive urinary biomarker-based risk score in the pre-biopsy setting for prostate cancer detection: a prospective study.
Gruppi di ricerca
Integrated Diagnostics in Prostate Cancer supported by Computational Algorithms (AI and network analysis)
Gruppi di ricerca - Responsabile
PROSTATE CANCER SCREENING IN HEALTHY MEN WITH DNA REPAIR GENE MUTATIONS: A GENDER PROSPECTIVE FOR A SUSTAINABLE PERSONALISED MEDICINE
Regenerative medicine-based treatment with injection of autologous muscle-derived or adipose-derived stem cells for the management of stress urinary incontinence : two preclinical models
VALORE PROGNOSTICO DELLE VARIANTI PATOGENETICHE DI GENI DDR (DNA DAMAGE REPAIR) NEI PAZIENTI CON NUOVA DIAGNOSI DI CARCINOMA PROSTATICO O DI NEOPLASIE DELLO STOMACO, PANCREAS E VIE BILIARI: IMPLICAZIONI DELL’ANALISI EREDO-FAMILIARE
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma